Guide to Vitamin D, 25-Hydroxy

WRITTEN BY
Updated: 05/22/2025|12 min read

Summary

Vitamin D is involved in many of your body's most important functions and affects nearly every cell in your body. The 25-hydroxy version is the predominant form, circulating in your blood for weeks to months.

Why It Matters

Vitamin D is a fat-soluble vitamin that plays an important role in keeping bones healthy. It also acts like a hormone and helps control genes that regulate immune function, emotional state, inflammation, cell growth, and neuromuscular function.

When vitamin D enters your body (either from sun exposure or diet), your liver converts it to 25-hydroxyvitamin D (calcidiol). This form serves as the body's main circulating storage form until it's needed, at which point specific tissues, primarily the kidneys, convert it to the active hormone form (calcitriol).

Measuring the 25-hydroxy form tells you if you're getting enough vitamin D to meet your body's needs. The test shows both the vitamin D you get from food and supplements, and what your body makes from sunlight exposure.

Understanding your vitamin D status is important because deficiency is common and can contribute to numerous health problems. Unlike water-soluble vitamins that your body can easily excrete if there is excess, vitamin D is fat-soluble and can build up, making it important to monitor both low and high levels.

Clinical Ranges

Lab Reference Range: 30-100 ng/mL

Symptoms of Conditions Associated with Abnormal Vitamin D Levels

Abnormal vitamin D status may be associated with certain health conditions, each with its own symptoms.

Conditions potentially associated with low vitamin D:

  • Bone disorders: Osteomalacia (adults) or rickets (children), resulting in bone pain, muscle weakness, and increased fracture risk
  • Muscle dysfunction: Proximal muscle weakness, pain, and impaired physical performance
  • Immune dysregulation: Increased susceptibility to infections, particularly respiratory infections
  • Autoimmune dysfunction or flare-ups: May be associated with low vitamin D due to its role in immune regulation and anti-inflammatory effects
  • Mood disorders: Depression, seasonal affective disorder, and other mood disturbances

Conditions potentially associated with high vitamin D (usually from excessive supplementation):

  • Hypercalcemia: Excessive calcium in the blood leading to nausea, poor appetite, confusion, and kidney problems
  • Kidney complications: Increased risk of kidney stones and potential kidney damage
  • Cardiovascular issues: Arrhythmia, with possible calcification of blood vessels with long-term excess

It's important to understand that the relationship between vitamin D and these conditions is complex and often bidirectional. Many factors beyond vitamin D influence these health conditions, and symptoms associated with vitamin D imbalances frequently overlap with symptoms of other nutritional or health issues.

Lifestyle Factors That Can Impact It

Factors that increase vitamin D levels include the following:

  • Sun exposure triggers natural vitamin D production in skin.
  • Fatty fish, egg yolk, and wild mushrooms like maitake provide dietary vitamin D.
  • Lifting weights may help maintain vitamin D status.

Factors that decrease vitamin D levels include the following:

  • Obesity isolates vitamin D in fat tissue, which lower circulating levels.
  • Limited dietary fat intake reduces vitamin D absorption from food.

Supplementation Considerations

If your vitamin D levels are suboptimal, your healthcare provider may recommend supplementation. Here are important considerations. You should always speak with your doctor before using a supplement.

Forms:

  • Vitamin D3 (cholecalciferol): Generally preferred as it's the form naturally produced from sun exposure and typically raises blood levels more effectively than D2
  • Vitamin D2 (ergocalciferol): Plant-derived form, sometimes prescribed in high doses but may be less effective at maintaining levels long-term

Dosage:

  • Can vary depending on needs and location; work with a medical professional to find the optimal dose for you.

Timing:

  • Take vitamin D supplements with a meal containing fat to improve absorption
  • Consistent daily supplementation is generally more effective than irregular large doses

Co-factors:

  • Magnesium is essential for vitamin D metabolism---deficiency may limit the effectiveness of vitamin D supplementation
  • Vitamin K2 is often recommended alongside vitamin D for bone and cardiovascular health
  • Zinc and boron play supporting roles in vitamin D function

Precautions:

  • Higher doses should be monitored with regular blood tests
  • People with certain conditions (sarcoidosis, some cancers, primary hyperparathyroidism) should consult a physician prior to supplementation
  • Those with a history of kidney stones should ensure adequate hydration when supplementing

Response time:

  • It typically takes 2-3 months of consistent supplementation to significantly raise vitamin D levels
  • Some people may require higher doses due to genetic differences in vitamin D metabolism, obesity, or malabsorption

Other Factors That Can Impact It

Medical Conditions

  • Celiac disease: decreases absorption of vitamin D
  • Crohn's disease: reduces vitamin D absorption
  • Liver disease: impairs vitamin D activation
  • Kidney disease: affects vitamin D metabolism
  • Gastric bypass surgery: reduces absorption area for vitamin D and calcium

Medications

  • Anticonvulsants: increases vitamin D metabolism, lowering circulating levels
  • Estrogen-containing contraceptives: can raise vitamin D by up to 20% while progestin-only contraceptives can lower it slightly
  • Sunscreens: Reduce vitamin D production by blocking UVB rays needed for skin synthesis of vitamin D 
  • Steroids: interferes with vitamin D metabolism
  • HIV medications: impairs vitamin D metabolism
  • Statins: may increase vitamin D levels
  • Orlistat: reduces fat and vitamin D absorption
  • Ketoconazole (antifungal): can interfere with vitamin D metabolism

Environmental Factors

  • Latitude: People living at higher or lower latitudes get less UVB exposure for vitamin D production, while people closer to the equator get more exposure.
  • Season: Winter months reduce vitamin D production.
  • Air pollution: Living in an area with pollution can reduce exposure to UVB rays.
  • Altitude: Higher elevation increases vitamin D production.

Testing Accuracy and Stability

While the vitamin D 25-hydroxy test is generally reliable, sunlight exposure, supplements, and time of year can affect results.

Factors That Can Affect Your Test Results

  • Recent sun exposure can increase levels, but excessive exposure can break down vitamin D in the skin.
  • Supplementation within 3--4 days of the test can elevate levels.
  • Levels are typically lower in winter.
  • Inflammation from a recent illness can temporarily lower levels.
  • Levels naturally increase during pregnancy.

How it Relates to Other Markers

Your vitamin D status influences and is influenced by several other important markers in your body. Understanding these relationships helps provide a complete picture of your health status. Key related markers to vitamin D 25-hydroxy include:

  • Calcium: Vitamin D controls calcium absorption and levels. Low vitamin D can cause calcium deficiency.
  • Phosphorus: Vitamin D regulates your phosphorus balance, so low phosphorus can be a sign of low vitamin D.
  • Parathyroid hormone: This hormone rises when vitamin D is low to help balance calcium levels.
  • Alkaline phosphatase: This enzyme increases with vitamin D deficiency as a result of balancing calcium levels.
  • Magnesium: This mineral is required for vitamin D activation. Low levels can decrease vitamin D absorption and metabolism.
  • Inflammation markers: Inflammation can lower vitamin D levels.
  • Kidney function tests: These show the body's ability to activate vitamin D.
  • Liver function tests: These tests indicate vitamin D processing capacity.

What Results May Mean in the Context of Other Markers

  • Low vitamin D, high PTH, and normal/low calcium: Can indicate vitamin D deficiency. Could also indicate hyperparathyroidism.
  • Low vitamin D, low calcium, low phosphate: Can indicate significant vitamin D deficiency affecting mineral metabolism and bone health.
  • Low Vitamin D, normal calcium, and normal PTH: May be early or moderate vitamin D insufficiency
  • Low Vitamin D + Elevated Inflammatory Markers: May be inflammation-induced vitamin D deficiency, seen in chronic inflammatory conditions, autoimmune diseases.
  • Low Vitamin D + Low Magnesium. Magnesium deficiency may be impairing vitamin D metabolism.
  • Low Vitamin D + Abnormal Kidney Function Tests: Can indicate chronic kidney disease. May need activated vitamin D forms rather than standard supplements.

Follow-up Considerations

If your vitamin D is low, your provider may work with you on steps to address the issue, including supplementation, retesting, and additional tests. You should always speak to your doctor if you have medical questions or before making medical decisions.

When Re-Testing May be Appropriate

  • Optimal levels: Every 6--12 months
  • Deficient levels: Every 3 months until normalized
  • High levels: Monthly until normalized
  • During supplementat
  • Seasonal changes: Spring and fall

When Additional Care May be Warranted

  • Levels < 20 ng/mL with symptoms
  • Levels >100 ng/mL
  • No improvement with supplementation
  • Persistent deficiency despite treatment
  • Unexplained high levels
  • Kidney stone history with high levels

Bibliography

References

1. Choi, Hyon K. "Gout and Other Crystal-Associated Arthropathies." Harrison's Principles of Internal Medicine, edited by Joseph Loscalzo et al., 21st ed., McGraw-Hill Education, 2022.

2. Sakhaee, Khashayar. "Epidemiology and Clinical Pathophysiology of Uric Acid Kidney Stones." Journal of Nephrology, vol. 27, no. 3, 2014, pp. 241--245. https://doi.org/10.1007/s40620-013-0034-z.

3. Moe, Orson W. "Kidney Stones: Pathophysiology and Medical Management." The Lancet, vol. 367, no. 9507, 2006, pp. 333--344. https://doi.org/10.1016/S0140-6736(06)68071-9.

4. Grases, Félix, Antonia Costa-Bauzá, and Raquel M. Prieto. "Renal Lithiasis and Nutrition." Nutrition Journal, vol. 5, 2006, article 23. https://doi.org/10.1186/1475-2891-5-23.

5. Cleveland Clinic. "Uric Acid Stones: Causes, Symptoms & Treatment." Cleveland Clinic, 2024, my.clevelandclinic.org/health/diseases/16378-uric-acid-stones.

6. George, Cindy, Steven W. Leslie, and Daniel A. Minter. "Hyperuricemia." StatPearls, StatPearls Publishing, 2025.

7. Leslie, Steven W., Hammad Sajjad, and Patrick B. Murphy. "Renal Calculi, Nephrolithiasis." StatPearls, StatPearls Publishing, 2025.

8. Gregg, Lisa P., et al. "Fatigue in CKD: Epidemiology, Pathophysiology, and Treatment." Clinical Journal of the American Society of Nephrology, vol. 16, no. 9, 2021, pp. 1445--1455. https://dx.doi.org/10.2215/CJN.19891220.

9. Li, Feng, et al. "Serum Uric Acid Levels and Metabolic Indices in an Obese Population: A Cross-Sectional Study." Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, vol. 14, 2021, pp. 627--635. https://dx.doi.org/10.2147/DMSO.S286299.

10. Kanbay, Mehmet, et al. "Uric Acid in Metabolic Syndrome: From an Innocent Bystander to a Central Player." European Journal of Internal Medicine, vol. 29, 2016, pp. 3--8. https://dx.doi.org/10.1016/j.ejim.2015.11.026.

11. Kushiyama, Akihiro, et al. "Role of Uric Acid Metabolism-Related Inflammation in the Pathogenesis of Metabolic Syndrome Components Such as Atherosclerosis and Nonalcoholic Steatohepatitis." Mediators of Inflammation, vol. 2016, 2016, article 8603164. https://doi.org/10.1155/2016/8603164.

12. Liu, Fang, et al. "Urine Uric Acid Excretion Levels Are Positively Associated with Obesity and Abdominal Obesity in Type 2 Diabetes Patients without Chronic Kidney Disease." Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, vol. 14, 2021, pp. 4691--4703. http://dx.doi.org/10.2147/DMSO.S335558.

13. Johnson, Richard J., et al. "Uric Acid and Chronic Kidney Disease: Which Is Chasing Which?" Nephrology Dialysis Transplantation, vol. 28, no. 9, 2013, pp. 2221--2228. https://doi.org/10.1093/ndt/gft029.

14. Causevic, Amela, et al. "Relevance of Uric Acid in Progression of Type 2 Diabetes Mellitus." Bosnian Journal of Basic Medical Sciences, vol. 10, no. 1, 2010, pp. 54--59. http://doi.org/10.17305/bjbms.2010.2736.

15. Mauer, Michael, and Alessandro Doria. "Uric Acid and Diabetic Nephropathy Risk." Contributions to Nephrology, vol. 192, 2018, pp. 103--109. http://dx.doi.org/10.1159/000484284.

16. Zhang, Yuqing, et al. "Low-Dose Aspirin Use and Recurrent Gout Attacks." Annals of the Rheumatic Diseases, vol. 73, no. 2, 2014, pp. 385--390. http://dx.doi.org/10.1136/annrheumdis-2012-202589.

17. Zhu, Bo, et al. "Prediction of Hyperuricemia in People Taking Low-Dose Aspirin Using a Machine Learning Algorithm: A Cross-Sectional Study of the National Health and Nutrition Examination Survey." Frontiers in Pharmacology, vol. 14, 2024, article 1276149. https://doi.org/10.3389/fphar.2023.1276149.

18. Wang, Y., et al. "Reduced Renal Function May Explain the Higher Prevalence of Hyperuricemia in Older People." Scientific Reports, vol. 11, 2021, article 1302. http://dx.doi.org/10.1038/s41598-020-80250-z.

19. Holick, Michael F. "Vitamin D Deficiency." The New England Journal of Medicine, vol. 357, no. 3, 2007, pp. 266--281. https://doi.org/10.1056/NEJMra070553.

20. Holick, Michael F., and Tai C. Chen. "Vitamin D Deficiency: A Worldwide Problem with Health Consequences." The American Journal of Clinical Nutrition, vol. 87, no. 4, 2008, pp. 1080S--1086S. https://doi.org/10.1093/ajcn/87.4.1080S.

21. Bikle, Daniel D. "Vitamin D: Production, Metabolism and Mechanisms of Action." Endotext, edited by Kenneth R. Feingold et al., MDText.com, Inc., 2000-.

22. DeLuca, Hector F. "Overview of General Physiologic Features and Functions of Vitamin D." The American Journal of Clinical Nutrition, vol. 80, no. 6, 2004, pp. 1689S--1696S. https://doi.org/10.1093/ajcn/80.6.1689S.

23. Pike, J. Wesley, and Mark B. Meyer. "Fundamental Principles of the Vitamin D Hormone-Regulated Gene Expression." Journal of Steroid Biochemistry and Molecular Biology, vol. 144, no. Pt A, 2014, pp. 5--11. http://doi.org/10.1016/j.jsbmb.2013.11.004.

24. Christakos, Sylvia, et al. "Vitamin D: Metabolism, Molecular Mechanism of Action, and Pleiotropic Effects." Physiological Reviews, vol. 96, no. 1, 2016, pp. 365--408. https://doi.org/10.1152/physrev.00014.2015.

25. Rosen, Clifford J., et al. "The Nonskeletal Effects of Vitamin D: An Endocrine Society Scientific Statement." Endocrine Reviews, vol. 33, no. 3, 2012, pp. 456--492. https://doi.org/10.1210/er.2012-1000.

26. Bouillon, Roger, et al. "Vitamin D and Human Health: Lessons from Vitamin D Receptor Null Mice." Endocrine Reviews, vol. 29, no. 6, 2008, pp. 726--776. https://doi.org/10.1210/er.2008-0004.

27. Jeon, Sang Min, and Eui A. Shin. "Exploring Vitamin D Metabolism and Function in Cancer." Experimental and Molecular Medicine, vol. 50, 2018, article 1. https://doi.org/10.1038/s12276-018-0038-9.

28. Samuel, Sam, and Michael D. Sitrin. "Vitamin D's Role in Cell Proliferation and Differentiation." Nutrition Reviews, vol. 66, suppl. 2, 2008, pp. S116--S124. https://doi.org/10.1111/j.1753-4887.2008.00094.x.

29. Lykstad, John, and Sandeep Sharma. "Biochemistry, Water Soluble Vitamins." StatPearls, StatPearls Publishing, 2025.

30. Aribi, M., et al. "The Role of Vitamin D as an Immunomodulator." Frontiers in Immunology, vol. 14, 2023, article 1186635. https://doi.org/10.3389/fimmu.2023.1186635.

31. Akpınar, Ş., and M. G. Karadağ. "Is Vitamin D Important in Anxiety or Depression? What Is the Truth?" Current Nutrition Reports, vol. 11, no. 4, 2022, pp. 675--681. http://dx.doi.org/10.1007/s13668-022-00441-0.

32. Nowak, Albina, et al. "Effect of Vitamin D3 on Self-Perceived Fatigue: A Double-Blind Randomized Placebo-Controlled Trial." Medicine, vol. 95, no. 52, 2016, article e5353. https://doi.org/10.1097/MD.0000000000005353.

33. Zittermann, Armin, and Stefan Pilz. "Vitamin D and Cardiovascular Disease: An Update." Anticancer Research, vol. 39, no. 9, 2019, pp. 4627--4635. http://dx.doi.org/10.21873/anticanres.13643.

34. Bejar, C. A., et al. "A Bidirectional Mendelian Randomization Study to Evaluate the Causal Role of Reduced Blood Vitamin D Levels with Type 2 Diabetes Risk in South Asians and Europeans." Nutrition Journal, vol. 20, 2021, article 71. http://dx.doi.org/10.1186/s12937-021-00725-1.

35. Zhang, Jian, and Zhi B. Cao. "Exercise: A Possibly Effective Way to Improve Vitamin D Nutritional Status." Nutrients, vol. 14, no. 13, 2022, article 2652. https://doi.org/10.3390/nu14132652.

36. Wacker, Matthias, and Michael F. Holick. "Sunlight and Vitamin D: A Global Perspective for Health." Dermatoendocrinology, vol. 5, no. 1, 2013, pp. 51--108. https://doi.org/10.4161/derm.24494.

37. Lehmann, Ute, et al. "Bioavailability of Vitamin D2 and D3 in Healthy Volunteers: A Randomized Placebo-Controlled Trial." Journal of Clinical Endocrinology & Metabolism, vol. 98, no. 11, 2013, pp. 4339--4345. http://doi.org/10.1210/jc.2012-4287.

38. Jäpelt, Rikke B., and Jakob Jakobsen. "Vitamin D in Plants: A Review of Occurrence, Analysis, and Biosynthesis." Frontiers in Plant Science, vol. 4, 2013, article 136. https://doi.org/10.3389/fpls.2013.00136.

39. Holick, Michael F. "Vitamin D Status: Measurement, Interpretation, and Clinical Application." Annals of Epidemiology, vol. 19, no. 2, 2009, pp. 73--78. https://doi.org/10.1016/j.annepidem.2007.12.001.

40. Williams, Stephen E. "Vitamin D Supplementation: Pearls for Practicing Clinicians." Cleveland Clinic Journal of Medicine, vol. 89, no. 3, 2022, pp. 154--160. http://dx.doi.org/10.3949/ccjm.89a.21021.

41. Amrein, Karin, et al. "Vitamin D Deficiency 2.0: An Update on the Current Status Worldwide." European Journal of Clinical Nutrition, vol. 74, no. 11, 2020, pp. 1498--1513. https://doi.org/10.1038/s41430-020-0558-y.

42. Uwitonze, Anne Marie, and Mohammed S. Razzaque. "Role of Magnesium in Vitamin D Activation and Function." Journal of the American Osteopathic Association, vol. 118, no. 3, 2018, pp. 181--189. https://doi.org/10.7556/jaoa.2018.037.

43. van Ballegooijen, Adriana J., et al. "The Synergistic Interplay between Vitamins D and K for Bone and Cardiovascular Health: A Narrative Review." International Journal of Endocrinology, vol. 2017, 2017, article 7454376. https://doi.org/10.1155/2017/7454376.

44. Amos, Alexander, and Mohammed S. Razzaque. "Zinc and Its Role in Vitamin D Function." Current Research in Physiology, vol. 5, 2022, pp. 203--207. http://dx.doi.org/10.1016/j.crphys.2022.04.001.

45. Miljkovic, Dragan, et al. "Up-Regulatory Impact of Boron on Vitamin D Function---Does It Reflect Inhibition of 24-Hydroxylase?" Medical Hypotheses, vol. 63, no. 6, 2004, pp. 1054--1056. http://dx.doi.org/10.1016/j.mehy.2003.12.053.

46. Zhang, Fei, and Wei Li. "The Complex Relationship between Vitamin D and Kidney Stones: Balance, Risks, and Prevention Strategies." Frontiers in Nutrition, vol. 11, 2024, article 1435403. https://doi.org/10.3389/fnut.2024.1435403.

47. Khan, Qaisar J., and Carol J. Fabian. "How I Treat Vitamin D Deficiency." Journal of Oncology Practice, vol. 6, no. 2, 2010, pp. 97--101. https://doi.org/10.1200/JOP.091087.

Sign up for the Levels Newsletter